Abstract

Objectives:Although gestational diabetes is the most common metabolic disease in pregnancy some pregnant women still refuse to undergo oral glucose tolerance test (OGTT). The purpose of this study was to evaluate the behavior of pregnant women undergoing OGTT, and to compare perinatal results between women who undergo and refuse OGTT.Methods:This retrospective cohort study was performed by evaluating the data of Izmir Katip Celebi University Gynecology and Obstetrics outpatient clinic between 2012-2017. Data of 2079 pregnant were evaluated retrospectively. Among 373 women who refused OGTT were evaluated as the study group, while remaining 1706 women who underwent OGTT were considered as the control group. The groups were compared with regard to perinatal results.Results:Sixty-two point four percent of the group who refused OGTT had a C-section, while 56.3% of the control group had a C-section (p<0.05). Intrauterine growth retardation, fetal distress, amniotic fluid pathologies, macrosomia, gestational hypertension and perinatal death were slightly higher in pregnant women who did not undergo OGTT compared to the control group, however, the difference was not statistically significant.Conclusion:Maternal complications and poor pregnancy results were found slightly higher in pregnant women who refused OGTT. These results might be explained by assuring glycemic control in pregnant women who refused OGTT by a series of fasting and postprandial blood sugar measurements in our center.

Highlights

  • Gestational diabetes is defined as a type of glucose intolerance that is first recognized in pregnancy

  • Among a total of 2079 pregnant women included in the study, 373 women who refused oral glucose tolerance test (OGTT) were evaluated as the study group, while remaining 1706 women were considered as the control group

  • Intrauterine growth restriction, fetal distress, amniotic fluid pathologies, macrosomia, gestational hypertension and perinatal death were slightly higher in pregnant women who did not undergo OGTT compared to control group

Read more

Summary

Introduction

Gestational diabetes is defined as a type of glucose intolerance that is first recognized in pregnancy. The prevalence of gestational diabetes (GDM) has been reported to be 14% across the globe and approximately 12.6% in Europe. Incidence of GDM has shown a progressive increase in recent years.[1,2]. Similar to other Mediterranean countries, Turkish society is a community with high GDM prevalence. A study performed in Germany, which is a country with high Turkish population, Turkish women living in the same area with German women were reported to have. Pak J Med Sci September - October 2021 Vol 37 No 5 www.pjms.org.pk 1486 higher GDM prevalence (13.8% versus 18.3%).[3] A recent multi-center study performed on Turkish population found that the prevalence was 16.2% across Turkey without any difference among regions.[4]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call